Asymptomatic Atherosclerosis in Egyptian Rheumatoid Arthritis Patients and Its Relation to Disease Activity
Table 3
Comparison of patients features between patients with and without atherosclerosis.
Patients without atherosclerosis ( = 77)
Patients with atherosclerosis ( = 35)
Mean ± SD
Mean ± SD
Age
34.9 ± 6.9
40.12 ± 6.5
Disease duration
4.7 ± 2.9
10.5 ± 3.1
DAS 28
2.85 ± 1.35
5.8 ± 1.5
Obesity (BMI)
26.7 ± 5.4
24.5 ± 8.2
0.23
Systolic BP (mm/Hg)
117.23 ± 8.13
120.29 ± 10.38
0.37
Diastolic BP
76.81 ± 4.83
78.82 ± 5.16
0.21
Us-CRP
48.48 ± 51.599
120.79 ± 53.89
Rheumatoid factor
87 ± 21.1
235.9 ± 37.8
0.5
Total cholesterol (mg/dL)
162.15 ± 28.6
175.7 ± 34.4
0.13
Triglycerides (mg/dL)
87.1 ± 30.6
98.8 ± 30.15
0.21
HDL (mg/dL)
43.33 ± 4.4
42.85 ± 3.3
0.07
LDL (mg/dL)
110.62 ± 31.45
123.24 ± 37.2
0.2
Cumulative steroid
748.21 ± 942.575
1335.88 ± 1621.50
HAQ
0.48 ± 0.09
0.49 ± 0.12
0.3
SENS
11.8 ± 1.9
13.4 ± 3.2
0.9
DAS 28 = disease activity score, BMI = body mass index, BP = blood pressure, Us-CRP = ultra sensitive c-reactive protein, IR = insulin resistance, HDL = high density lipoprotein, LDL = low density lipoprotein, HAQ = health assessment questionnaire. SENS = Simple Erosion Narrowing Score. Moderate significant and highly significant.
